Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level survey

References

• Torales J, O'Higgins M, Castaldelli-Maia JM, Ventriglio AThe outbreak of COVID-19 coronavirus and its impact on global mental healthInt J Soc Psychiatry2020664317320 10.1177/0020764020915212 32233719
   PubMed Web of Science ®Google Scholar
• Sinnott SJ, Smeeth L, Williamson E, Douglas IJTrends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995–2015BMJ201722358 10.1136/bmj.j3984
   Google Scholar
• Heald AH, Stedman M, Davies M, Livingston M, Taylor D, Gadsby RAntidepressant prescribing in England: patterns and costsPrim Care Companion CNS Disord.202022219m02552 10.4088/PCC.19m02552 32302071
   PubMedGoogle Scholar
• COVID-19 Mental Disorders CollaboratorsGlobal prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemicLancet20213981031217001712 10.1016/S0140-6736(21)02143-7
   PubMed Web of Science ®Google Scholar
• OpenPrescribing.net, Bennett Institute for Applied Data Science, University of Oxford.
   Google Scholar
• English Prescribing monthly dataset https://opendata.nhsbsa.net/dataset/english-prescribing-data-epd: accessed 22 July 2022.
   Google Scholar
• Mansfield KE, Mathur R, Tazare J, Henderson AD, Mulick AR, Carreira H, Matthews AA, Bidulka P, Gayle A, Forbes H, Cook S, Wong AYS, Strongman H, Wing K, Warren-Gash C, Cadogan SL, Smeeth L, Hayes JF, Quint JK, McKee M, Langan SMIndirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based studyLancet Digit Health202134e217e230 1:CAS:528:DC%2BB3sXis1Snu7w%3D 10.1016/S2589-7500(21)00017-0 33612430 7985613
   PubMedGoogle Scholar
• Jacob L, Smith L, Koyanagi A, Oh H, Tanislav C, Shin JI, Konrad M, Kostev KImpact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in GermanyJ Psychiatr Res2021143528533 10.1016/j.jpsychires.2020.11.029 33243457
   PubMed Web of Science ®Google Scholar
• Estrela M, Silva TM, Gomes ER, Piñeiro M, Figueiras A, Roque F, Herdeiro MTPrescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approachJ Epidemiol Community Health2022764335340 10.1136/jech-2021-216732 34625519
   PubMed Web of Science ®Google Scholar
• Heald AH, Stedman M, Tian Z, Wu P, Fryer AAModelling the impact of the mandatory use of face coverings on public transport and in retail outlets in the UK on COVID-19-related infections, hospital admissions and mortalityInt J Clin Pract2021753e13768 1:CAS:528:DC%2BB3MXlvVChsbw%3D 10.1111/ijcp.13768 33070412
   PubMed Web of Science ®Google Scholar
• Daly M, Robinson EDepression and anxiety during COVID-19Lancet202239910324518 1:CAS:528:DC%2BB38XpvFGru7s%3D 10.1016/S0140-6736(22)00187-8 35123689 8813060
   PubMed Web of Science ®Google Scholar
• Howard R, Burns A, Schneider LAntipsychotic prescribing to people with dementia during COVID-19Lancet Neurol20201911892 1:CAS:528:DC%2BB3cXit1Grsb7N 10.1016/S1474-4422(20)30370-7 33098796 7577650
   PubMed Web of Science ®Google Scholar
• https://bnf.nice.org.uk/treatment-summaries/antidepressant-drugs: accessed 22 July 2022.
   Google Scholar
• Goyal DK, Mansab F, Naasan AP, Iqbal A, Millar C, Franklin G, Thomas S, McFadden J, Burke D, Lasserson DRestricted access to the NHS during the COVID-19 pandemic: is it time to move away from the rationed clinical response?Lancet Reg Health Eur20218 10.1016/j.lanepe.2021.100201 34423329 8372453
   PubMedGoogle Scholar
• Pujolar G, Oliver-Anglès A, Vargas I, Vázquez MLChanges in Access to Health Services during the COVID-19 pandemic: a scoping reviewInt J Environ Res Public Health20221931749 1:CAS:528:DC%2BB38Xkt12lurY%3D 10.3390/ijerph19031749 35162772 8834942
   PubMed Web of Science ®Google Scholar
• Yan D, Temkin-Greener H, Cai SDid the COVID-19 pandemic affect the use of antipsychotics among nursing home residents with ADRD?Am J Geriatr Psychiatry2023312124140 10.1016/j.jagp.2022.09.009 36272888
   PubMed Web of Science ®Google Scholar
• Umaharan T, Sivayokan S, Sivansuthan SAmitriptyline dependence and its associations: a case report and literature reviewCase Rep Psychiatry20212920216647952 10.1155/2021/6647952
   Google Scholar
• Alam A, Voronovich Z, Carley JAA review of therapeutic uses of mirtazapine in psychiatric and medical conditionsPrim Care Companion CNS Disord.2013 10.4088/PCC.13r01525 24511451 3907331
   PubMedGoogle Scholar